Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28,862,386
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
3,055,824
-
Shares change
-
+147,000
-
Total reported value, excl. options
-
$60,046,863
-
Value change
-
+$2,780,074
-
Number of buys
-
27
-
Number of sells
-
18
-
Price
-
$19.63
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q4 2017
As of 31 Dec 2017 abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) had 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,055,824 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, Claraphi Advisory Network, LLC, FLAGSHIP HARBOR ADVISORS, LLC, WELLS FARGO & COMPANY/MN, COHEN & STEERS INC, Invesco Ltd., LPL Financial LLC, and LADENBURG THALMANN FINANCIAL SERVICES INC..
This table shows 53 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.